Toggle menu

4AT Study

Start date:
August 2015
End date:
Predicted June 2017
Co-ordinated by:
EMERGE team on behalf of University of Edinburgh and NHS Lothian
Main trial site:

The 4AT as a triage test for delirium: a validation study in acutely hospitalised older patients.


To determine the diagnostic accuracy of the 4AT for delirium versus the reference standard of a DSM-IV diagnosis

Trial Design

Patients undergo a standard delirium assessment, and either the 4AT or the Confusion Assessment Method (CAM). Clinical outcomes and resource utilisation are recorded at 12 weeks after admission.

Eligibility criteria

Patients aged over 70 admitted to the Emergency Department.

Chief Investigator

Professor Alasdair MacLullich

Professor of Geriatric Medicine

Research Team

Allan MacRaild

Stroke Lead Research Nurse

Jill Steven

Senior Research Nurse - 4AT study

Mia Paderanga

Senior Research Nurse

Megan McGrath

Senior Research Nurse

Emma Ward

Research Administrator

Related news

4AT team attends British Geriatric Society conference

4AT team attends British Geriatric Society conference

5 Nov 2015 | Allan MacRaild

Emerge sent two research nurses to the British Geriatric Society (BGS) conference. Jill Steven and Allan MacRaild are recruiting to a study entitled The 4AT as a triage test for delirium: a validation study in acutely hospitalised older patients. This study is a first collaboration between Emerge and Medicine of the Elderly with this study being led by Professor Alasdair MacLullich.

Read more
A study to assess a tool to diagnose Delirium

More EMERGE Trials

ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study

ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)

Diagnostics devices play an important part in the clinical assessment of a patient’s health and treatment. The purpose of the study is the evaluation of a new diagnostic platform developed by LumiraDx. The evaluation is focused around various biomarkers useful in the emergency settings.

Read more


Collection of venous and capillary blood samples for the evaluation of new diagnostic devices for cardiovascular conditions

TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.

Read more